{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:32:34Z","timestamp":1776213154959,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2012CB517700"],"award-info":[{"award-number":["2012CB517700"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202297"],"award-info":[{"award-number":["81202297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10067-017-3596-7","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T01:46:31Z","timestamp":1490406391000},"page":"1023-1029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China"],"prefix":"10.1007","volume":"36","author":[{"given":"Chun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. R.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. F.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. N.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. T.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. F.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. T.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. B.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Q.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. M.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. X.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. D.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. G.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"3596_CR1","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka T, Abelson B, Pincus T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26:S35\u2013S61","journal-title":"Clin Exp Rheumatol"},{"key":"3596_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/art.10705","volume":"48","author":"SE Gabriel","year":"2003","unstructured":"Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O\u2019Fallon WM, Matteson EL (2003) Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 48:54\u201358","journal-title":"Arthritis Rheum"},{"key":"3596_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/ard.2006.059980","volume":"67","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez A, Maradit KH, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O\u2019Fallon WM, Gabriel SE (2008) Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients. Ann Rheum Dis 67:64\u201369","journal-title":"Ann Rheum Dis"},{"key":"3596_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jbspin.2006.01.014","volume":"73","author":"T Pham","year":"2006","unstructured":"Pham T, Gossec L, Constantin A, Pavy S, Bruckert E, Cantagrel A, Combe B, Flipo RM, Goupille P, Le LX, Mariette X, Puechal X, Schaeverbeke T, Sibilia J, Tebib J, Wendling D, Dougados M (2006) Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73:379\u2013387","journal-title":"Joint Bone Spine"},{"issue":"9","key":"3596_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","volume":"34","author":"JF Restrepo","year":"2015","unstructured":"Restrepo JF, Del RI, Battafarano DF, Haas RW, Doria M, Escalante A (2015) Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol 34(9):1529\u20131536","journal-title":"Clin Rheumatol"},{"key":"3596_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325\u2013331","journal-title":"Ann Rheum Dis"},{"key":"3596_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1136\/ard.2010.145482","volume":"70","author":"CS Crowson","year":"2011","unstructured":"Crowson CS, Gabriel SE (2011) Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 70:719\u2013721","journal-title":"Ann Rheum Dis"},{"key":"3596_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/annrheumdis-2013-203911","volume":"72","author":"PH Dessein","year":"2013","unstructured":"Dessein PH, Semb AG (2013) Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced. Ann Rheum Dis 72:1743\u20131746","journal-title":"Ann Rheum Dis"},{"key":"3596_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","volume":"74","author":"EE Arts","year":"2014","unstructured":"Arts EE, Popa C, Den BAA, Semb AG, Toms T, Kitas GD, van Riel PL, Fransen J (2014) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74:668\u2013674","journal-title":"Ann Rheum Dis"},{"key":"3596_CR10","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar2045","volume":"8","author":"VP Halm van","year":"2006","unstructured":"van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151","journal-title":"Arthritis Res Ther"},{"key":"3596_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14656566.9.7.1121","volume":"9","author":"J Avouac","year":"2008","unstructured":"Avouac J, Allanore Y (2008) Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opin Pharmacother 9:1121\u20131128","journal-title":"Expert Opin Pharmacother"},{"key":"3596_CR12","doi-asserted-by":"publisher","unstructured":"Bili A, Tang X, Pranesh S, Bozaite R, DO SJ, Antohe JL, Kirchner HL, Wasko MC (2013) TNF-alpha inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 66:355\u2013363.","DOI":"10.1002\/acr.22166"},{"key":"3596_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/art.22418","volume":"56","author":"JM Davis 3rd","year":"2007","unstructured":"Davis JM 3rd, Maradit KH, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56:820\u2013830","journal-title":"Arthritis Rheum"},{"key":"3596_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","volume":"216","author":"L Rodriguez-Rodriguez","year":"2011","unstructured":"Rodriguez-Rodriguez L, Gonzalez-Juanatey C, Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA (2011) TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 216:125\u2013130","journal-title":"Atherosclerosis"},{"key":"3596_CR15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/ard.2008.094151","volume":"68","author":"VP Halm van","year":"2009","unstructured":"van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68:1395\u20131400","journal-title":"Ann Rheum Dis"},{"key":"3596_CR16","doi-asserted-by":"publisher","unstructured":"(1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413\u20132446","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"3596_CR17","first-page":"1903","volume":"35","author":"F Bobbio-Pallavicini","year":"2008","unstructured":"Bobbio-Pallavicini F, Caporali R, Bugatti S, Montecucco C (2008) What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated peptide antibodies. J Rheumatol 35:1903\u20131905","journal-title":"J Rheumatol"},{"key":"3596_CR18","unstructured":"World Health Organization Western Pacific Region\/IASO\/IOTF (2000) The Asia\u2013Pacific perspective: redefining obesity and its treatment. Sydney"},{"key":"3596_CR19","first-page":"945","volume":"35","author":"NJ Goodson","year":"2008","unstructured":"Goodson NJ, Farragher TM, Symmons DP (2008) Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis. J Rheumatol 35:945\u2013949","journal-title":"J Rheumatol"},{"key":"3596_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03009740410006899","volume":"33","author":"N Erb","year":"2004","unstructured":"Erb N, Pace AV, Douglas KM, Banks MJ, Kitas GD (2004) Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 33:293\u2013299","journal-title":"Scand J Rheumatol"},{"key":"3596_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/ard.2009.115717","volume":"69","author":"TE Toms","year":"2010","unstructured":"Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP, Symmons DP, Nightingale P, Metsios GS, Kitas GD (2010) Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk. Ann Rheum Dis 69:683\u2013688","journal-title":"Ann Rheum Dis"},{"key":"3596_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","volume":"38","author":"G Steiner","year":"2009","unstructured":"Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372\u2013381","journal-title":"Semin Arthritis Rheum"},{"key":"3596_CR23","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1186\/ar4396","volume":"15","author":"A Sandoo","year":"2013","unstructured":"Sandoo A, Chanchlani N, Hodson J, Smith JP, Douglas KM, Kitas GD (2013) Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. Arthritis Res Ther 15:R203","journal-title":"Arthritis Res Ther"},{"key":"3596_CR24","doi-asserted-by":"publisher","first-page":"R134","DOI":"10.1186\/ar4314","volume":"15","author":"CP Chung","year":"2013","unstructured":"Chung CP, Giles JT, Kronmal RA, Post WS, Gelber AC, Petri M, Szklo M, Detrano R, Budoff MJ, Blumenthal RS, Ouyang P, Bush D, Bathon JM (2013) Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther 15:R134","journal-title":"Arthritis Res Ther"},{"key":"3596_CR25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, Williams P (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49:1483\u20131489","journal-title":"Rheumatology (Oxford)"},{"key":"3596_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/acr.20393","volume":"63","author":"SJ Morris","year":"2011","unstructured":"Morris SJ, Wasko MC, Antohe JL, Sartorius JA, Kirchner HL, Dancea S, Bili A (2011) Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 63:530\u2013534","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3596_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1475-097X.1993.tb00381.x","volume":"13","author":"CN Anigbogu","year":"1993","unstructured":"Anigbogu CN, Adigun SA, Inyang I, Adegunloye BJ (1993) Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults. Clin Physiol 13:209\u2013216","journal-title":"Clin Physiol"},{"key":"3596_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.090994","volume":"37","author":"SK Penn","year":"2010","unstructured":"Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, Manzi S, Wasko MC (2010) Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 37:1136\u20131142","journal-title":"J Rheumatol"},{"key":"3596_CR29","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/art.22053","volume":"54","author":"PH Dessein","year":"2006","unstructured":"Dessein PH, Joffe BI (2006) Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 54:2765\u20132775","journal-title":"Arthritis Rheum"},{"key":"3596_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","volume":"112","author":"A Quatraro","year":"1990","unstructured":"Quatraro A, Consoli G, Magno M, Caretta F, Nardozza A, Ceriello A, Giugliano D (1990) Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug. Ann Intern Med 112:678\u2013681","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"3596_CR31","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1177\/096120339600500105","volume":"5","author":"M Petri","year":"1996","unstructured":"Petri M (1996) Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5(Suppl 1):S16\u2013S22","journal-title":"Lupus"},{"key":"3596_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.298.2.187","volume":"298","author":"MC Wasko","year":"2007","unstructured":"Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM (2007) Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 298:187\u2013193","journal-title":"JAMA"},{"key":"3596_CR33","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJM199906173402418","volume":"340","author":"PL Weissberg","year":"1999","unstructured":"Weissberg PL, Bennett MR (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340:1928\u20131929","journal-title":"N Engl J Med"},{"key":"3596_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480\u2013489","journal-title":"Ann Rheum Dis"},{"issue":"730","key":"3596_CR35","first-page":"e9-730","volume":"126","author":"DH Solomon","year":"2013","unstructured":"Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA (2013) Cardiovascular risk in rheumatoid arthritis: comparing TNF-alpha blockade with nonbiologic DMARDs. Am J Med 126(730):e9-730\u2013e9-e17","journal-title":"Am J Med"},{"key":"3596_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/rheumatology\/kes006","volume":"51","author":"S Mathieu","year":"2012","unstructured":"Mathieu S, Pereira B, Dubost JJ, Lusson JR, Soubrier M (2012) No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. Rheumatology (Oxford) 51:1107\u20131111","journal-title":"Rheumatology (Oxford)"},{"key":"3596_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"E Choy","year":"2009","unstructured":"Choy E, Sattar N (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 68:460\u2013469","journal-title":"Ann Rheum Dis"},{"key":"3596_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/art.38920","volume":"67","author":"VU Rao","year":"2015","unstructured":"Rao VU, Pavlov A, Klearman M, Musselman D, Giles JT, Bathon JM, Sattar N, Lee JS (2015) An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol 67:372\u2013380","journal-title":"Arthritis Rheumatol"},{"key":"3596_CR39","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1097\/MD.0000000000000888","volume":"94","author":"F Ursini","year":"2015","unstructured":"Ursini F, Russo E, Letizia HM, Mauro D, Savarino F, Bruno C, Tripolino C, Rubino M, Naty S, Grembiale RD (2015) Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) 94:e888","journal-title":"Medicine (Baltimore)"},{"key":"3596_CR40","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/art.24308","volume":"59","author":"C Gonzalez-Juanatey","year":"2008","unstructured":"Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA (2008) Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum 59:1821\u20131824","journal-title":"Arthritis Rheum"},{"key":"3596_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/kes243","volume":"52","author":"KP Liao","year":"2013","unstructured":"Liao KP, Solomon DH (2013) Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford) 52:45\u201352","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3596-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T07:42:37Z","timestamp":1492760557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3596-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3596"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3596-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}